HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab.

AuthorsHans-Peter Hartung
JournalThe Lancet. Neurology (Lancet Neurol) Vol. 8 Issue 1 Pg. 28-31 (Jan 2009) ISSN: 1474-4422 [Print] England
PMID19081511 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • Interferon-beta
  • Azathioprine
Topics
  • Adult
  • Antibodies, Monoclonal (adverse effects, pharmacokinetics, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Azathioprine (therapeutic use)
  • Female
  • Humans
  • Interferon-beta (therapeutic use)
  • Leukoencephalopathy, Progressive Multifocal (cerebrospinal fluid, etiology, pathology)
  • Magnetic Resonance Imaging
  • Male
  • Multiple Sclerosis, Relapsing-Remitting (complications, drug therapy)
  • Natalizumab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: